Kaleido Biosciences said on March 24 the company’s experimental oral treatment cut recovery time as well as hospitalizations and emergency room visits in patients with mild to moderate Covid-19, in an early trial.
Common cold antibodies hold clues to Covid-19 behavior; lung scans speed Covid-19 diagnosis in stroke patientsAdults, Children, Common cold antibodies, Computed Tomography (CT) Scans, Coronavirus Disease 2019 (COVID-19), Covid-19 Pneumonia, Emergency Rooms, Hospitalized COVID-19 Patients, Infected Cells, Lung Imaging, Medical Journals, Novel Coronavirus, Science, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Strokes
In a Reuters roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for Covid-19, common cold antibodies yield clues to Covid-19 behavior.
Eli Lilly and Co. is seeking emergency use authorization from the U.S. health regulator for the company’s experimental Covid-19 antibody monotherapy and plans to pursue a similar approval for a combination therapy with two of its antibody drugs in November 2020.
Post COVID-19: Telemedicine is the new Urgent CareConsumers, Coronavirus Disease (COVID-19) Pandemic, Doctors, Emergency Rooms, HCPs, Healthcare Communications Agencies, Healthcare Physicians, Hospitals, Market Research, Marketing & Advertising, Medical Professionals, Sales Reps, Series C Financing, Series D Financing, Telemedicine, Urgen Care Centers
The COVID-19 global pandemic, overcrowding of hospitals, the highly contagious virus affecting healthcare professionals and unrelated illnesses has led to a more than 1,000 percent increase of telemed application downloads and memberships. Is this a paradigm shift?
First Antibiotic With New Mechanism of Action Approved in Almost 20 YearsAntibiotics, Approvals, Community-Acquired Bacterial Pneumonia (CABP), Emergency Departments, Emergency Rooms, European Medicines Agency (EMA), Fast Track Designation, FDA, FDA/Regulatory, Priority Review, U.S. Centers for Disease Control and Prevention, Wholesale Acquisition Cost
The U.S. FDA gave Nabriva Therapeutics a thumbs-up for the company’s oral and intravenous formulations of Xenleta (lefamulin) to treat community-acquired bacterial pneumonia in adults.
Opiant Pharmaceuticals Inc. announced an agreement with Sanofi to manufacture Opiant’s investigational agent OPNTOO4 (drinabant) for the treatment of Acute Cannabinoid Overdose.
(Reuters Health) – U.S. emergency rooms are increasingly running short on medications, including many that are needed for life-threatening conditions, a recent study documents. Since 2008, the number of shortages […]
(Reuters Health) – In a new study, people who arrive at the emergency room with severe low back pain didn’t experience more relief with muscle relaxants or opioids than with […]
(Reuters Health) Dietary supplements – those “all natural” products people consume for weight loss, extra energy or to self-treat various conditions – send 23,000 people, many of them children, to […]
A new blood test might help doctors figure out faster whether someone’s having a heart attack. The test reliably told doctors which patients were not having heart attacks after only […]